Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Blood Vessel Breakthrough Major Step Towards Alzheimers Treatment
A breakthrough in our understanding of Alzheimer’s disease has revealed changes to blood vessels in […]
Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, […]
Neurovation Labs Awarded Additional Air Force Phase II Contract Worth $1.25M to Develop Tools to Mitigate PTSD and Other Brain Traumas
Neurovation Labs, Inc., a biotechnology company developing the first objective diagnostic and companion treatment for […]
Naobios Delivers Flugen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of […]
MicroTransponder Raises $53M, Appoints New CEO
MicroTransponder®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment […]
Börje Haraldsson Appointed Ceo of Oncorena AB
Oncorena AB, which is developing a new and potentially groundbreaking treatment for patients with advanced […]
Therorna Completes Series A Financing to Accelerate Pipeline Development and Clinical Transformation of circRNA-based Platform
Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) […]
BIOTEM Implements New Industrial Unit Dedicated to Development and Production of Immunoassays
BIOTEM, a hybrid Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) focusing on high […]
DTx Leader Sidekick Enters Strategic Collaboration With Lilly to Support Patients With Breast Cancer
International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), today announces an integrated digital therapeutics solution in conjunction […]
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more